Exploring Exosomes as Next Generation Diagnostic Biomarkers to Unlock Liquid Biopsy Potential for Early Disease Detection

• Leveraging exosome cargo such as RNA, proteins, and lipids as stable, disease-specific biomarkers in accessible biofluids
• Advancing liquid biopsy approaches to enable earlier detection of cancer, neurodegeneration, and inflammatory diseases
• Improving sensitivity and specificity through enrichment and high-resolution molecular profiling techniques

Speakers:

Kanika Suri

Senior Scientist & CMC Lead

Independent